sodium (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro- 1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12- carboxylate
sodium (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro- 1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12- carboxylate Basic information
- Product Name:
- sodium (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro- 1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12- carboxylate
- Synonyms:
-
- sodium (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro- 1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12- carboxylate
- Eburnamenine-14-carboxylic acid, 14,15-dihydro-, (3α,16α)
- sodium (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]phthyridine-12-carboxylate
- Vinpocetine-23
- Eburnamenine-14-carboxylic acid, 14,15-dihydro-, (3α,16α)
- Eburnamenine-14-carboxylic acid, 14,15-dihydro-, (3α,16α)- (9CI)
- CAS:
- 55821-92-6
- MF:
- C20H24N2O2
- MW:
- 324.42
- Mol File:
- 55821-92-6.mol
More
Less
sodium (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro- 1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12- carboxylate Chemical Properties
- Boiling point:
- 536.8±50.0 °C(Predicted)
- Density
- 1.39±0.1 g/cm3(Predicted)
- pka
- 3.85±0.40(Predicted)
sodium (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro- 1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12- carboxylateSupplier
Beijing Comparison Pharmaceutical Technology Co., Ltd
- Tel
- 010-52878169 15701683040
- sales@bjcomparison.com
Wuxi Zhongkun Biochemical Technology Co., Ltd.
- Tel
- 0510-85629785 18013409632
- sales@reading-chemicals.com
Anhui Feixiang Pharmaceutical Technology Co., Ltd.
- Tel
- 13349001619
- sales@feixiangpharm.com
Guangzhou Dreampharm Biotechnology Co., Ltd.
- Tel
- 17825480238
- 3008233717@qq.com
Standardpharm Co. Ltd.
- Tel
- 86-714-3992388
- overseasales1@yongstandards.com
More
Less
sodium (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro- 1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12- carboxylate(55821-92-6)Related Product Information
- (+)-(14β)-Dihydrovinpocetine
- methyl (41R,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
- methyl (3alpha,14alpha,16alpha)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylate
- methyl (41R,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
- methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
- methyl (41R,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
- ethyl apovincaminate
- ApovincaMinic Acid Ethyl Ester N-Oxide
- apovincamine
- 16,17-Dihydroapovincamine
- Vinpocetine
- (41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid
- methyl (41S,12R,13aR)-13a-ethyl-12- hydroxy-2,3,41,5,6,12,13,13aoctahydro- 1H-indolo[3,2,1- de]pyrido[3,2,1-ij][1,5]naphthyridine- 12-carboxylate
- methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-8-methoxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
- ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
- (-)-DihydroapovincaMinic Acid Ethyl Ester
- (3alpha,16alpha)-eburnamenine-14-carboxylic acid
- EBURNAMENINE-14-CARBOXYLIC ACID, 14,15-DIHYDRO-14-HYDROXY-, ETHYL ESTER, (3A,14B,16A)-